LIDOCAINE HCL 4%- lidocaine hcl 4% ointment 
CHAIN DRUG MARKETING ASSOCIATION INC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

QC Pain Relieving Cream + Lidocaine
Lidocaine HCl 4%

Lidocaine HCl 4%

benzyl alcohol, carbomer, hydrogenated lecithin, polysorbate 80, propylene glycol, purified water, triethanolamine, vitamin E

Adults and children 12 years and older: apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 to 4 applications in a 24-hour period.

BEFORE AND AFTER APPLYING, WASH HANDS WITH SOAP AND WATER.

Children under 12 years: ask a doctor

temporary relieves minor joint and muscle pain

For external use only

Do not use on large areas of the body or on cut, irritated or swollen skin, on puncture wounds, for more than one week without consulting a doctor.

When using this product use only as directed. Read and follow all directions and warnings on this carton, do not allow contact with the eyes, do not bandage or apply local heat (such as heating pads) to the area of use.

Stop use and ask a doctor if condition worsens, symptoms persist for more than 7 days or clear up and occur again within a few days.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children and pets.

If swallowed, get medical help or contact a Poison Control Center right away.

Keep out of reach of children and pets.

If swallowed, get medical help or contact a Poison Control Center right away.

Topical anesthetic

1

LIDOCAINE HCL 4% 
lidocaine hcl 4% ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-451
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)  
WATER (UNII: 059QF0KO0R)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CARBOMER 940 (UNII: 4Q93RCW27E)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
TROLAMINE (UNII: 9O3K93S3TK)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63868-451-7276.5 g in 1 BOTTLE; Type 0: Not a Combination Product10/28/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34810/28/2020
Labeler - CHAIN DRUG MARKETING ASSOCIATION INC (011920774)

Revised: 4/2022
Document Id: dc792777-d8b5-3ebc-e053-2a95a90abc3f
Set id: b2c1e5a4-4482-2ba7-e053-2995a90a944b
Version: 2
Effective Time: 20220412
 
CHAIN DRUG MARKETING ASSOCIATION INC